Stacy Cozad - Feb 26, 2021 Form 4/A - Amendment Insider Report for Ingevity Corp (NGVT)

Role
EVP, Gen. Counsel & Secretary
Signature
/s/ Stacy L. Cozad
Stock symbol
NGVT
Transactions as of
Feb 26, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/17/2021, 08:12 PM
Date Of Original Report
Mar 2, 2021
Next filing
Feb 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGVT Employee Stock Option (right-to-buy) Award $0 +4.31K $0.00 4.31K Feb 26, 2021 Common Stock 4.31K $69.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's Form 4 filed with the SEC on March 2, 2021 inadvertently reported an incorrect exercise price with respect to the Employee Stock Option (right-to-buy). This amendment is being filed solely to correct the exercise price and remove an erroneous price entry in Section 8 of Table II.
F2 These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023 and 2024.